Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate

被引:79
作者
Gupta, D [1 ]
Raju, J [1 ]
Prakash, RJ [1 ]
Baquer, NZ [1 ]
机构
[1] Jawaharlal Nehru Univ, Sch Life Sci, Hormone & Drug Metab Res Lab, New Delhi 110067, India
关键词
lipids; lipogenic enzymes; diabetes; insulin; vanadate;
D O I
10.1016/S0168-8227(99)00067-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Administration of sodium orthovanadate to diabetic animals exhibits insulin-like effects and has been effective in the reversal of biochemical complications. This study evaluates the effect of sodium orthovanadate (0.6 mg/ml) treatment for 21 days on the hepatic glucose homeostasis and lipid metabolism in alloxan diabetic rats. The activities of two lipogenic enzymes, glucose-6-phosphate dehydrogenase and malic enzyme; and related enzymes, hexokinase and glucose-6-phosphatase were measured in the liver cytosolic fractions of diabetic rats and diabetic rats treated separately with insulin and sodium orthovanadate. The total lipids, triglycerides and cholesterol levels were estimated in the livers of the diabetic and the treated rats. The activities of both the lipogenic enzymes and hexokinase isozymes were significantly decreased, whereas the activity of glucose-6-phosphatase was significantly increased in the diabetic liver. During diabetes, the levels of total lipids and triglycerides increased significantly with a decrease in the cholesterol levels in the liver. Insulin and vanadate were able to restore the altered enzyme activities to almost control levels. Both insulin and vanadate were found to partially restore the altered levels of total lipids, triglycerides and cholesterol in the livers of diabetic rats. The results indicate that vanadate administration to diabetic animals normalizes blood glucose and causes marked improvement of altered lipid metabolism during diabetes. The present study and earlier reports suggest the possible use of vanadate as insulin replacement in the therapy of diabetes when administered at pharmacological doses. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 30 条
[1]  
Arky R., 1982, COMPLICATIONS DIABET, P16
[2]  
Baginsky ES, 1974, METHOD ENZYMAT AN, V2
[3]   Regulation of metabolic pathways in liver and kidney during experimental diabetes: Effects of antidiabetic compounds [J].
Baquer N.Z. ;
Gupta D. ;
Raju J. .
Indian Journal of Clinical Biochemistry, 1998, 13 (2) :63-80
[4]  
Baquer Najma Zaheer, 1998, Anales de la Real Academia de Farmacia, V64, P147
[5]   EFFECTS OF THYROID-HORMONE DEFICIENCY ON DISTRIBUTION OF HEPATIC METABOLITES AND CONTROL OF PATHWAYS OF CARBOHYDRATE-METABOLISM IN LIVER AND ADIPOSE-TISSUE OF RAT [J].
BAQUER, NZ ;
CASCALES, M ;
MCLEAN, P ;
GREENBAUM, AL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1976, 68 (02) :403-413
[6]   Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes [J].
Elberg, G ;
He, ZB ;
Li, JP ;
Sekar, N ;
Shechter, Y .
DIABETES, 1997, 46 (11) :1684-1690
[7]  
Fiske CH, 1925, J BIOL CHEM, V66, P375
[8]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[9]  
FRINGS CS, 1972, CLIN CHEM, V18, P673
[10]   METABOLIC EFFECTS OF SODIUM METAVANADATE IN HUMANS WITH INSULIN-DEPENDENT AND NONINSULIN-DEPENDENT - DIABETES-MELLITUS IN-VIVO AND IN-VITRO STUDIES [J].
GOLDFINE, AB ;
SIMONSON, DC ;
FOLLI, F ;
PATTI, ME ;
KAHN, CR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) :3311-3320